CCM
MGCD

Cadence Capital Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Cadence Capital Management’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-111,431
Closed -$1.27M – 667
2014
Q1 		$1.27M Buy
111,431
+63,161
+131% +$714K 0.05% 399
2013
Q4 		$611K Buy
+48,270
New +$590K 0.02% 514

Other funds holding MGCD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFA
Nationwide Fund Advisors Columbus, Ohio $2.28B AUM 12.16% 1-Year Est. Return
HAMF
Hatteras Alternative Mutual Funds Raleigh, North Carolina $221M AUM 39.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cadence Capital Management's MGCD Position: Q2 2014 in Review

Cadence Capital Management sold out of MGC Diagnostics Corporation (MGCD) in Q2 2014, closing a stake of 111,431 shares — an estimated $1.27M sold.

Cadence Capital Management first reported a position in MGCD in Q4 2013 and held it in 2 quarters. The position peaked at $1.27M in Q1 2014. 19 funds tracked by Wall St. Rank hold MGCD as of Q2 2014.

  • Cadence Capital Management reported no remaining MGC Diagnostics Corporation position as of Q2 2014 after selling out during the quarter.
  • Cadence Capital Management sold 111,431 MGC Diagnostics Corporation shares in Q2 2014, an estimated $1.27M.
  • Cadence Capital Management first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 2 quarters.
  • Cadence Capital Management's MGC Diagnostics Corporation position peaked at $1.27M in Q1 2014.
  • 19 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q2 2014.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.